You are here:
IRIS Toxicological Review of Hexavalent Chromium (2010 External Review Draft)
Federal Register Notices
Notice - This site contains archived material(s)
Archived files are provided for reference purposes only. The file was current when produced, but is no longer maintained and may now be outdated. Persons with disabilities having difficulty accessing archived files may contact the NCEA Webmaster for assistance. Please use the contact us form if you need additional assistance.
In September 2010, EPA released a draft IRIS assessment for hexavalent chromium, for the oral route of exposure only, for peer review and public comment. An independent expert peer review panel met in May 2011 to review the draft assessment. In their final report, the peer review panel urged EPA to consider the results of research that would soon be completed and peer-reviewed that could provide relevant scientific information that may inform the findings of the assessment.
EPA takes seriously its commitment to rigorous independent expert peer review. Based on the advice of the peer review panel, EPA will review original primary research related to the health effects of hexavalent chromium that has been published since the release of the draft assessment for external peer review and will incorporate the findings as appropriate into its hexavalent chromium assessment.
Chromium is a naturally occurring element in the earth's crust. The three main forms of chromium found in the environment are chromium (0), chromium (III), and chromium (VI), also known as hexavalent chromium. Chromium is widely used in manufacturing processes, and it can be found in many consumer products such as wood treated with copper dichromate, leather tanned with chromic sulfate, and stainless steel cookware. Chromium is released to the environment from natural and anthropogenic sources, with the largest releases occurring from industrial sources. The general population may be exposed to chromium by inhaling ambient air, and ingesting food and drinking water containing chromium. Dermal exposure to chromium can occur from skin contact with certain consumer products or soils that contain chromium.
|Sep 1998||The oral RfD for hexavalent chromium was posted to the IRIS database. The inhalation RfC for hexavalent chromium and the carcinogenicity assessment for hexavalent chromium were also posted to the IRIS database.|
|May 2010||EPA initiated an interagency science consultation to review the draft toxicological review and charge to external peer reviewers.|
|Sep 2010||EPA released the external review draft for public review and comment and the interagency science consultation review draft with comments. EPA also announced a public listening session to be held on November 18, 2010. [Federal Register Sep 30, 2010]|
|Nov 2010||EPA extended the public comment period an additional 30-days. [Federal Register Nov 10, 2010]|
|Apr 2011||EPA has announced that the peer review panel workshop on the draft assessment for Hexavalent Chromium will be held on May 12, 2011 in Arlington, VA. [Federal Register Apr 12, 2011]|
|Jul 2011||EPA releases the comments from the public comment period and external review workshop.|
This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.